Valcrest Pharmaceuticals Overview

  • Founded
  • 2015

Founded
  • Status
  • Private

  • Latest Deal Type
  • Angel

  • Latest Deal Amount
  • $50K

Valcrest Pharmaceuticals General Information

Description

Developer of pharmaceutical products intended for treating rare diseases. The company specializes in the development and commercialization of pharmaceutical products to address the needs of patients with ultra-rare orphan diseases, helping people get rid of diseases easily.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Pharmaceuticals
Primary Office
  • 520 White Plains Road
  • Suite 500
  • Tarrytown, NY 10591
  • United States
+1 (914) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Valcrest Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Angel (individual) 27-Mar-2015 $50K 0000 Completed Generating Revenue
To view Valcrest Pharmaceuticals’s complete valuation and funding history, request access »

Valcrest Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of pharmaceutical products intended for treating rare diseases. The company specializes in the development and
Pharmaceuticals
Tarrytown, NY
0000
0000000000 0000

000000

dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut ali
000000000000000
Ingelheim am Rhein, Germany
00000 As of 0000

000000

Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo co
000000000000000
Mexico City, Mexico
0000 As of 0000
000.00
0000000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Valcrest Pharmaceuticals Competitors (23)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Boehringer Ingelheim Corporation Ingelheim am Rhein, Germany 00000
00000000000 000000 Private Equity-Backed Mexico City, Mexico 0000 000.00 0000000 0000
00000000 000000000 Formerly VC-backed Allschwil, Switzerland 0000 00000 000000&0 00000
0000000 Corporation Gaithersburg, MD 0000 00000 000000000 00000
0000000000 0000000 Corporation San Francisco, CA 000 000000&0
You’re viewing 5 of 23 competitors. Get the full list »

Valcrest Pharmaceuticals Executive Team (2)

Name Title Board Seat Contact Info
Kenneth Greathouse Chief Executive Officer & Co-Founder
Brian Smith President and Manager
To view Valcrest Pharmaceuticals’s complete executive team members history, request access »